Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
221 to 240 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01CA215052 | Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and Progression | 1 | 2025 |
| R01CA240290 | Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells | 1 | 2025 |
| R01CA241752 | Targeting MUC5AC mucin in breast cancer brain metastasis | 1 | 2025 |
| R01CA245386 | c-Myc modulation and its implications in EGFR-targeted cancer therapy | 1 | 2025 |
| R01CA246133 | Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis | 1 | 2025 |
| R01CA246547 | CD4+ T cells and neoantigens in melanoma immunotherapy. | 1 | 2025 |
| R01CA248288 | Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk | 1 | 2025 |
| R01CA249528 | Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance | 1 | 2025 |
| R01CA253329 | Role of microbially-derived metabolites in anti-tumor immunity in breast cancer | 1 | 2025 |
| R01CA255021 | A pro-metastatic secretory pathway activated by p53 loss in lung cancer | 1 | 2025 |
| R01CA256480 | AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS | 1 | 2025 |
| R01CA256741 | A non-canonical role for EZH2 in rRNA methtlation | 1 | 2025 |
| R01CA258231 | Vitamin K: Body Pools and Function in Breast Cancer | 1 | 2025 |
| R01CA260691 | Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma | 1 | 2025 |
| R01CA262241 | PTP1b Inhibition Restores the Innate Anti-tumor Response During Chemotherapy | 1 | 2025 |
| R01CA262794 | EPHA2 Receptor Signaling in Breast Cancer Mechanotransduction | 1 | 2025 |
| R01CA265095 | Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia | 1 | 2025 |
| R01CA267103 | Targeting the FBXO44/SUV39H1 Pathway in Cancer | 1 | 2025 |
| R01CA268597 | The integrated stress response and the microenvironment in melanoma progression | 1 | 2025 |
| R01CA273054 | Regulation of Mitochondrial Metabolism by Tyr-phosphorylated ATP Synthase Alpha-Subunit and its Therapeutic Implications in Prostate Cancer | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=12